Pharma IQ will be
holding its BioPatent Design conference on September 7-9, 2010 in Munich,
Germany.  The conference will allow
attendees to:

• Gain first time
patent approval by implementing global patent office best practices, with
representation from the EPO, IPO, DMPA, and USPTO;
• Withstand
incoming patent attacks by analyzing global patenting strategies to build
robust patents;
• Maximize patent
revenue by incorporating lessons learned from best practice lifecycle management
strategies; and
• Implement best
practice strategies for specific patent types, including diabetes, gene
patents, and antibodies.

In particular, the
conference will offer presentations on the following topics:

• Keynote
presentation:  Ensuring first time
approval for biotech invention patents: 
The USPTO perspective — David Kappos, Director, U.S. patent and
Trademark Office;
• Keynote
presentation:  Understanding the
recent EPO's standards and rule changes and the ultimate impact on your
business — John Beatty, Patent Procedures Management, European Patent Office;
• Panel
discussion:  Multi jurisdictional
Patent Office approval standards;
• Trends for
biopatents at German Patent and Trademark Office;
• Spotlight
session:  Ensuring first time
approval for biotech invention patents;
• Exclusivity
extensions:  Opportunities and
limits of employing SPC's and paediatric extensions to maximize protection;
• The current state
of the new European Bolar-type provisions;
• The consequences
for biotech patenting of the European Union patent and litigation system;
• Developing a
robust patenting strategy on a per product/project basis;
• Spotlight
session:  Rolling out a global
patent strategy for biological drugs;
• Biogenerics and
biosimilars:  At the interface
between patents and data exclusivity;
• Strategies for
global protection of therapeutic antibodies today and tomorrow;
• Obtaining
meaningful therapeutic antibody claims in the new millennium;
• Assessing
patentability of mature and growth areas of pharmaceutical patents:  Diabetes vs. stem cells;
• Patent protection
for gene sequences; and
• Recent biotech
case law decisions and the impact on the industry.

The agenda for the
BioPatent Design conference can be found here (Day 1) and here (Day 2).  A complete brochure for this
conference, including an agenda, list of speakers, and registration form can be
downloaded here.

A post-conference
workshop, entitled "Successfully Drafting Biotech and Pharma Patent
Applications," will be offered on September 9, 2010.  The interactive session will provide
practical tips on drafting and prosecuting biotech and pharmaceutical patent
applications before the European Patent Office and the U.S. Patent and
Trademark Office.

The registration
fees for the conference and focus day are as follows: €1.749 (conference alone) and €2.298 (conference and post-conference
workshop).  Those interested in
registering for the conference can do so here,
by e-mailing enquire@iqpc.co.uk,
calling +44 (0)20 7368 9300, or faxing +44 (0)20 7368 9301.